Atorvastatin September update for anyone taking for high cholesterol in UK after test results
Atorvastatin reduced major cardiovascular event risk by 30% compared with placebo but ‘death risk’ remained same Atorvastatin reduced major cardiovascular event risk by 30% compared with placebo but ‘death risk’ remained same Lancs Live – NewsRead More